Empowering Primary Care Through Evidence

PEER is a primary care led evidence based medicine team focused on providing relevant evidence to family physicians and primary care providers.

MEME CONFERENCE 2022

In Person and Online -May 27 & 28th, 2022


The Best Science Medicine Course returns as the MEME Conference (Making Evidence Matter for Everyone), May 27 & 28, online and in Vancouver, BC.  From the clinicians who brought you Tools for Practice, BS Medicine Podcast, and the Meds Conference, our event is evidence-based with no sponsorship and funded entirely by registration fees – we make evidence fun!  

CFPCLearn’s primary care focused library includes a variety of content including evidence summaries, videos, podcasts and interactive learning courses to support clinicians in their practice.

Most Recent Tools for Practice

Tools for Practice #314 Weight to Go: Naltrexone/bupropion for weight loss

Is naltrexone/bupropion (Contrave®) effective for weight loss?

Over 28-56 weeks, at best, ~50% of patients taking naltrexone/bupropion achieved a >5% loss in body weight, compared to ~20% in control. Naltrexone/bupropion adverse events (examples nausea, constipation) lead to withdrawal in 23% of patients versus 12% on placebo. Read More

Tools for Practice #313 Gastrointestinal bleeding – Does tranexamic acid halt it or not?

Does tranexamic acid reduce mortality or other clinically significant outcomes in gastrointestinal bleeds?

In acute gastrointestinal bleeds, tranexamic acid does not reduce mortality, transfusions, surgical interventions, or intensive care stay compared to placebo and should not be routinely used. Read More

Tools for Practice #312 Thirsty for weight loss ideas? Water for weight loss

Does increasing water lead to meaningful weight loss?

The effects of water on weight are uncertain due to inconsistent results, in small-moderate size studies with widely variable designs and compliance issues. Replacing caloric beverages with diet beverages or water inconsistently improved weight loss and differences between diet beverages and water was even less clear. Preloading water (500ml) before meals may improve weight loss by 1-2kg over 3 months. Read More

Tools for Practice #311 “Ultralong”-acting insulin for diabetes: How long is long enough?

In patients with diabetes (type 1 or 2), how does the “ultralong”-acting insulin degludec compare to long-acting or NPH insulin?

In both type 1 and 2 diabetes, insulin degludec reduces the risk of severe hypoglycemia compared to insulin glargine [number needed to treat (NNT)=17-59]. The risk of symptomatic hypoglycemia is either similar, or at best lower with degludec (NNT=19-29), with no other differences in clinical outcomes or hemoglobin A1c. Read More

Tools for Practice #310 Medications for Heart Failure with Preserved or Mildly-Reduced Ejection Fraction: Heart Failure or Heart Success?

Which medications reduce death or hospitalization in patients with heart failure (HF) with preserved or mildly-reduced ejection fraction (EF >40%)?

In patients with HF with EF >40%, only mineralocorticoid receptor antagonists (MRA) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce HF hospitalizations, and nothing has been shown to reduce death. Compared to placebo, one patient avoids HF hospitalization for every 41 receiving an MRA for ~3 years, or for every 32 receiving an SGLT2i for ~2 years. Read More

PEER Values

When creating primary care education and programs, the PEER team focuses on minimizing bias, patient orientated outcomes, shared decision making, collaboration and most importantly simplicity.

Who is PEER?

Patients, Experience, Evidence and Research (PEER) was formed between a group of primary care providers who shared a common belief that evidence should be made accessible to all primary care providers. 

Follow @peerevidence on Instagram

Our Partners

Sign Up for the PEER Newsletter

Don’t miss out on the latest from PEER. Get first access the latest PEER research and notified when PEER releases new guidelines and tools.